are we all looking at the same thing? (slightly edited from my late post to yesterday’s thread)
Korean study of 100 patients was released and talked about today. Citing chloroquine use on the recommendation of China (30 days after the fact)**.
The French micro-study used Placquenil paired with Azithromycin, an antibiotic. (Did the CCP whisper to France, too?)
U of Queensland will conduct a much larger study to look at the efficacy of the treatment on viral suppression, but also the possible role of hydroxychloroquine’s buffering aspect in preventing cytokine storm (and the role of cytokines in supercharging viral replication)...
*Treating COVID-19 with chloroquine, as is being done in South Korea and China does have the potential to lead to a mutation.
**In early February, Chongqing Kangle Pharmaceutical was requested...to promptly increase...production of... chloroquine phosphate
I’m referring to this
To answer your question, blueplum, I believe so.
Chloroquine and hydroxychlroquine are slightly different though.
And in the French study, they combined hydroxychlroquine & zithromycin.
blueplum wrote:
“are we all looking at the same thing? (slightly edited from my late post to yesterday’s thread)
Korean study of 100 patients was released and talked about today. Citing chloroquine use on the recommendation of China (30 days after the fact)**.
The French micro-study used Placquenil paired with Azithromycin, an antibiotic. (Did the CCP whisper to France, too?)
U of Queensland will conduct a much larger study to look at the efficacy of the treatment on viral suppression, but also the possible role of hydroxychloroquine’s buffering aspect in preventing cytokine storm (and the role of cytokines in supercharging viral replication)...
*Treating COVID-19 with chloroquine, as is being done in South Korea and China does have the potential to lead to a mutation.
**In early February, Chongqing Kangle Pharmaceutical was requested...to promptly increase...production of... chloroquine phosphate